Read + Share
Chan OSH, Lam KC, Li JYC, Choi FPT, et al. ATOM: A phase II study to assess efficacy of preemptive local ablative therapy to
residual oligometastases of NSCLC after EGFR TKI. Lung Cancer 2020;142:41-46.
PMID: 32088604
|
 |
|
Chan OSH, Lam KC, Li JYC, Choi FPT, et al. ATOM: A phase II study to assess efficacy of preemptive local ablative therapy to
residual oligometastases of NSCLC after EGFR TKI. Lung Cancer 2020;142:41-46.
PMID: 32088604
|
|
|
|